Trials / Completed
CompletedNCT00447811
Study Evaluating MOA-728 in Subjects on Stable Methadone Maintenance
Two Ascending Single Doses Crossover, Placebo Controlled Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MOA-728 Administered Orally to Subjects on Stable Methadone Maintenance
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Bausch Health Americas, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This is a study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of MOA-728 in subjects on stable methadone maintenance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MOA-728 |
Timeline
- Start date
- 2007-03-01
- Completion
- 2007-05-01
- First posted
- 2007-03-15
- Last updated
- 2019-11-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00447811. Inclusion in this directory is not an endorsement.